Articles

Find out about changes to choline salicylate access, starting from October 2023.

On 29 August 2023, the TGA executed multiple warrants on storage units and residences in Brisbane and seized over 40,000 vaping products with an estimated street value of over $1.2 million

Find out how Product Information inserts won’t be required in the packaging of injectable medicines, given by health professionals, starting from September 2023.

We have issued infringement notices for $26,640 to Nius Development Pty Ltd for the alleged unlawful import of unapproved cosmetic injectable products.

The TGA has issued 7 infringement notices totalling $115,500 to the company for the alleged unlawful advertising and supply of sport supplement products containing banned substances.

Information about the TGA's safety monitoring of COVID-19 vaccines.

Companies supplying medicines in Australia will be required to provide additional information if their products go into shortage.

Information about the TGA's safety monitoring of COVID-19 vaccines.

The TGA has issued five infringement notices totalling $82,500 were issued to the company, and 3 notices totalling $9,900 were issued to an individual.

Information about the TGA's safety monitoring of COVID-19 vaccines.

Read about our import, advertising and supply compliance priorities for 2023-24.

Understand the Medicines Safety Update for July 2023 - Information for health professionals and consumers.

Information about the TGA's safety monitoring of COVID-19 vaccines.

Find out how the prescribing and dispensing requirements for MS-2 Step have changed.

We have issued 8 infringement notices totalling $105,600 to Nature’s Puff Pty Ltd and a director, for the alleged unlawful advertising of nicotine vaping products.

If you're a sponsor, it's important to be aware of the global issue of nitrosamine impurities in medicines. Find out what steps you should take.

This International Coalition of Medicines Regulatory Authorities (ICMRA) statement provides the general public with important information regarding the safety of COVID-19 vaccines, which have now been in use for more than two years.

The Government has agreed that regulatory amendments should be drafted to extend the transition arrangements for certain medical device reforms to 1 July 2029.

Stay updated about the commencement of MDMA and psilocybin for the treatment of certain mental illnesses.

Find out how listed medicine ingredients, and requirements for their use, have been updated in the latest Therapeutic Goods (Permissible Ingredients) Determination.

Information about the TGA's safety monitoring of COVID-19 vaccines.

Understand the Medicines Safety Update for June 2023 - Information for health professionals and consumers.

To help sponsors and manufacturers transition to new manufacturer evidence.

Information about the TGA's safety monitoring of COVID-19 vaccines.

The TGA has provisionally approved Pfizer’s bivalent COVID-19 vaccine, tozinameran and riltozinameran (COMIRNATY Original/Omicron BA.1) for use as a booster dose in adults 18 years and over.